Happify Health Raises $73M in Series D Funding

Happify Health

Happify Health, a NYC-based global software-enabled healthcare platform to improve mental and physical health, raised $73m in Series D funding.

The round was led by Deerfield Management Company and included participation from Omega Capital Partners, ION Crossover Partners, and existing investors.

The company intends to use the funds to expand its healthcare platform, focused on digital therapeutics and patient care delivery, expanding the Digital Therapeutics and Care Delivery solutions and pursuing global business development opportunities. The new funding will help further drive relationships with pharmaceutical companies through configurable digital therapeutics solutions and specialized solutions for enterprise and health plan customers. The capital will also help support additional investment into developing advances in Artificial Intelligence and Machine Learning-based models that power Anna, a software-based coach designed to support and engage individuals for several chronic conditions, most notably mental health.

Led by Tomer Ben-Kiki, Co-Founder and CEO, and Ofer Leidner, President and Co-Founder, Happify Health is a global software-enabled healthcare platform focused on improving mental and physical health. The solution utilizes an evidence-based approach that delivers scientifically-validated programs which positively impact behavior to help manage chronic conditions alongside providing access to solutions such as telehealth, AI-powered coaching and access to therapeutics, as required, to improve peoples’ everyday lives. Happify Health offers two core solutions for its customers and end-users; Digital Therapeutics and Care Delivery solutions and services across the healthcare ecosystem, including enterprises, health plans, health systems, pharmaceutical manufacturers, and individuals. Today, the platform is available globally in 10 languages, supports more than 10 chronic conditions, and covers more than 20 million lives.

FinSMEs

17/03/2021